According to Adaptimmune Therapeutics's latest financial reports the company's current earnings (TTM) are -โน6.32 B. In 2023 the company made an earning of -โน9.57 B an increase over its 2022 earnings that were of -โน13.59 B.The earnings displayed on this page is the company's Pretax Income.